Milestone Scientific (NYSE:MLSS) Now Covered by StockNews.com

StockNews.com began coverage on shares of Milestone Scientific (NYSE:MLSS) in a research note issued to investors on Wednesday. The brokerage set a “hold” rating on the stock.

Separately, Benchmark reiterated a “speculative buy” rating and set a $1.25 price objective on shares of Milestone Scientific in a report on Wednesday, November 20th.

Milestone Scientific Trading Up 0.8 %

Shares of NYSE MLSS opened at $1.28 on Wednesday. The firm has a market capitalization of $99.70 million, a P/E ratio of -18.28 and a beta of 1.10. The firm’s 50-day moving average price is $0.99 and its 200-day moving average price is $0.93. Milestone Scientific has a 1-year low of $0.54 and a 1-year high of $1.39.

Institutional Investors Weigh In On Milestone Scientific

A number of hedge funds have recently made changes to their positions in MLSS. Geode Capital Management LLC increased its holdings in Milestone Scientific by 6.4% during the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after buying an additional 31,572 shares during the last quarter. World Investment Advisors LLC purchased a new position in Milestone Scientific in the third quarter valued at about $91,000. Y Intercept Hong Kong Ltd bought a new position in shares of Milestone Scientific during the 3rd quarter valued at approximately $48,000. Finally, Carnegie Investment Counsel increased its stake in shares of Milestone Scientific by 18.9% during the 4th quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock worth $166,000 after purchasing an additional 27,412 shares during the last quarter. 5.79% of the stock is currently owned by institutional investors.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.